NCI Definition: A malignant tumor arising from the endothelial cells of the blood vessels. Microscopically, it is characterized by frequently open vascular anastomosing and branching channels. The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei. Angiosarcomas most frequently occur in the skin and breast. Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. [1]

Angiosarcomas most frequently harbor alterations in TP53, MYC, KDR, PIK3CA, and FLT4 [2].

Most Commonly Altered Genes in Angiosarcoma

TP53 Mutation, MYC Amplification, TP53 c.217-c.1178 Missense, TP53 Missense, and KDR Mutation are the most common alterations in angiosarcoma [2].

Top Alterations in Angiosarcoma

Significant Genes in Angiosarcoma



Disease Details

Malignant Angioendothelioma, Malignant Hemangioendothelioma, Hemangiosarcoma, HEMANGIOSARCOMA, MALIGNANT
Malignant Vascular Neoplasm
Bone Angiosarcoma, Central Nervous System Angiosarcoma, Ovarian Angiosarcoma, Thyroid Gland Angiosarcoma, Conventional Angiosarcoma, Aortic Angiosarcoma, Mediastinal Angiosarcoma, Skin Angiosarcoma, Breast Angiosarcoma, Prostate Angiosarcoma, Childhood Angiosarcoma, Superior Vena Cava Angiosarcoma, Splenic Angiosarcoma, Liver Angiosarcoma, and Gallbladder Angiosarcoma
OncoTree Name
OncoTree Code


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.